Exploring the potential of using glycated hemoglobin to prevent the onset of type 1 diabetes mellitus in diabetic ketoacidosis state in children
Abstract
Introduction. High rates of diabetic ketoacidosis (DKA) at type 1 diabetes (T1D) onset in children are linked to delayed diagnosis. HbA1c levels rise before clinical manifestation, but its utility as a first-line screening test remains insufficiently studied. Aim. To analyze HbA1c levels in relation to manifestation severity, age, and symptom duration in children with newly diagnosed T1D. Materials and methods . The study included 128 children (median age 11.0 years) diagnosed with T1D in 2024–2025. HbA1c levels were analyzed based on the presence of DKA, age, and symptom duration. Results. The median HbA1c at admission was 11.9% [10.1; 13.8]. HbA1c was significantly higher in DKA cases: 12.9% vs. 11.45% without DKA (p = 0.004). No significant age-related differences were found (p = 0.297). A moderate positive correlation was observed between HbA1c and symptom duration (r = 0.34; p < 0.001). In patients with symptoms ≤7 days (n = 48), the median HbA1c was 10.6%; 21 of them were asymptomatic, and 6 presented with DKA. In this subgroup, DKA was also associated with significantly higher HbA1c (12.5%). Conclusions . HbA1c levels at T1D onset significantly exceed the diagnostic threshold, correlate with severity and symptom duration, and are independent of age. High HbA1c in asymptomatic cases confirms a period of silent dysglycemia. HbA1c is a promising first-line tool for mass screening programs aimed at early T1D detection and DKA prevention.